Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

alpha-Amino-beta-lactam carbamates as systemic NAAA inhibitors

Sep. 25, 2014

Once-weekly GH replacement therapy with MOD-4023 shows promise in pediatric patients

Sep. 23, 2014

AGI-12026, a novel potent and selective IDH2 R140Q inhibitor shows promise in vivo

Sep. 23, 2014

Adenium Biotech presents a novel antibacterial peptide for Gram-negative bacteria

Sep. 23, 2014

GeNeuro presents novel clinical and preclinical results for GNbAC-1

Sep. 23, 2014

Preclinical and phase I results presented for LY-2452473

Sep. 23, 2014

Direct inhibition of InhA to combat drug-resistant TB

Sep. 23, 2014

Research looks into role of betatrophin in human diabetes and its potential as a biomarker

Sep. 22, 2014

USP7 gene polymorphisms linked to breast cancer susceptibility in Chinese women

Sep. 22, 2014

BA-321, a selective androgen receptor modulator for treatment of male osteoporosis

Sep. 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...